Clinical Trials Logo

Filter by:
NCT ID: NCT04572412 Completed - Covid19 Clinical Trials

Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia

Start date: November 25, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to document the feasibility and tolerability of low dose thoracic radiotherapy in patients with WHO level 5 COVID 19 infections.

NCT ID: NCT04570904 Completed - Influenza Clinical Trials

Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness

BELIEVE
Start date: September 28, 2020
Phase:
Study type: Observational

This study uses a prospective cohort design to investigate if the seasonal influenza vaccine is equally effective when given early and late before the proceeding influenza season. All health care workers will be vaccinated for seasonal influenza either 3 months before or 1 month prior to the start of the influenza season. HCWs that consent to take part in the study will have 4 blood samples taken for an antibody check. The initial antibody checks will be done just prior to vaccination as well as 2 weeks after vaccination. Subsequent samples will be taken at the peak of influenza season and at the end of the influenza season. HCWs that develop ILI during the course of the influenza season will be asked to complete a questionnaire and oropharyngeal self-swab. HCWs will also provide exhaled breath samples and wear a mask in order to evaluate novel non-invasive methods for diagnosis of influenza. Influenza positive and negative inpatients identified through the University of Leicester's laboratory system will also be asked to provide breath samples to evaluate this technique for the diagnosis of influenza.

NCT ID: NCT04570657 Completed - Asthma Clinical Trials

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

FRONTIER-3
Start date: September 17, 2020
Phase: Phase 2
Study type: Interventional

Study D9181C00001 is a Phase II, randomised, double-blind, placebo-controlled, parallel group, proof of concept study to evaluate the efficacy, safety, pharmacokinetics (PK) and immunogenicity of MEDI3506 in adult participants with uncontrolled moderate to severe asthma on standard of care (SOC). Up to approximately 80 sites globally will participate in this study. Approximately 228 participants will be randomized to 3 treatment groups in a 1:1:1 ratio to receive MEDI3506 dose 1, MEDI3506 dose 2, or placebo.

NCT ID: NCT04569110 Completed - Pleural Infection Clinical Trials

The Microbiology of Pleural Infection

TORPIDS
Start date: February 10, 2019
Phase:
Study type: Observational

Pleural Infection (PI) is a common, severe and complicated disease with considerable morbidity and mortality. (1,2) The knowledge of pleural infection microbiology remains incomplete. Sequencing of the bacterial 16S rRNA gene is a reliable methodology to discover the total microbiome of complex samples. The investigators designed a translational metagenomics study to study the bacteriology of pleural infection. The investigators will use pleural fluid specimens from a) the "Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study" (3) clinical trial and b) non-pleural infection patients. The pleural fluid specimens will be subjected to 16S rRNA next generation sequencing.

NCT ID: NCT04568629 Completed - Terminal Illness Clinical Trials

ADJUST: A Study on MDT Prognostication

ADJUST
Start date: October 15, 2020
Phase: N/A
Study type: Interventional

This study investigates how clinicians form intuitive judgements about the prognoses of palliative care patients after receiving advice perceived as coming from either a team member or an algorithm.

NCT ID: NCT04568434 Completed - Clinical trials for Familial Chylomicronemia Syndrome

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)

BALANCE
Start date: November 16, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the efficacy of Olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.

NCT ID: NCT04568317 Completed - Depression Clinical Trials

Smartwatch-supported Internet-delivered Intervention for Depression

Start date: November 30, 2020
Phase: N/A
Study type: Interventional

The current study seeks to investigate the acceptance of the use of a smartwatch in an internet-delivered Cognitive Behavioural Therapy (CBT) based intervention for depression.

NCT ID: NCT04568083 Completed - Clinical trials for Myocardial Infarction (MI)

Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice

ALETHEIA
Start date: September 25, 2020
Phase:
Study type: Observational

This is an observational study based on secondary data extracted from multiple register-based data sources in the US and Europe (Sweden, United Kingdom, Italy, Germany). The study will include patients initiating treatment with ticagrelor 60 mg after a myocardial infarction in real-world clinical practice, and describe their patient characteristics and duration of treatment. If the a priori threshold of 5,000 person-years on treatment with ticagrelor 60 mg is met, outcome events (bleeding and cardiovascular events) will also be analysed and described.

NCT ID: NCT04568057 Completed - Clinical trials for Age-related Cognitive Decline

Effect of Transcranial NIR Light Upon Memory

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

A double-blind placebo-controlled study evaluating the effect of 1068nm NIR trans-cranial phototherapy upon the cognitive function of healthy individuals between the age of 45 years and 80 years.

NCT ID: NCT04567472 Completed - Stroke Clinical Trials

HEADS: UP Online Psychological Self-management Intervention: Feasibility 2

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

To test feasibility of online version of HEADS: UP